Chris Lewis
Stock Analyst at Roth Capital
(3.09)
# 1,298
Out of 4,996 analysts
13
Total ratings
77.78%
Success rate
62.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chris Lewis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGNT Cognyte Software | Reinstates: Buy | $4 | $8.35 | -52.10% | 5 | Nov 8, 2017 | |
| IRMD IRADIMED CORPORATION | Reinstates: Buy | $16 | $70.27 | -77.23% | 3 | Oct 31, 2017 | |
| AXGN Axogen | Initiates: Buy | $15 | $17.16 | -15.50% | 1 | Mar 6, 2017 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $53.57 | - | 3 | Feb 22, 2017 | |
| IRIX IRIDEX | Initiates: Buy | $20 | $1.15 | +1,639.13% | 1 | Dec 21, 2016 |
Cognyte Software
Nov 8, 2017
Reinstates: Buy
Price Target: $4
Current: $8.35
Upside: -52.10%
IRADIMED CORPORATION
Oct 31, 2017
Reinstates: Buy
Price Target: $16
Current: $70.27
Upside: -77.23%
Axogen
Mar 6, 2017
Initiates: Buy
Price Target: $15
Current: $17.16
Upside: -15.50%
Exact Sciences
Feb 22, 2017
Upgrades: Buy
Price Target: n/a
Current: $53.57
Upside: -
IRIDEX
Dec 21, 2016
Initiates: Buy
Price Target: $20
Current: $1.15
Upside: +1,639.13%